Detalhe da pesquisa
1.
Clinical Utility of the Risk Analysis Index as a Prospective Frailty Screening Tool within a Multi-practice, Multi-hospital Integrated Healthcare System.
Ann Surg
; 274(6): e1230-e1237, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32118596
2.
Electronic enhancements to blood ordering reduce component waste.
Transfusion
; 56(3): 564-70, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26559520
3.
Very low rate of patient-related adverse events associated with the use of intraoperative cell salvage.
Transfusion
; 56(11): 2768-2772, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27614051
4.
Association of Routine Preoperative Frailty Assessment With 1-Year Postoperative Mortality.
JAMA Surg
; 158(5): 475-483, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811872
5.
Increasing Quality and Frequency of Goals-of-Care Documentation in the Highest-Risk Surgical Candidates: One-Year Results of the Surgical Pause Program.
JB JS Open Access
; 8(2)2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101601
6.
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19.
JAMA Netw Open
; 5(4): e226920, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412625
7.
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.
Contemp Clin Trials
; 113: 106652, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34896293
8.
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial.
Contemp Clin Trials
; 119: 106822, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697146
9.
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.
JAMA Netw Open
; 5(7): e2220957, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834252
10.
SafeNET: Initial development and validation of a real-time tool for predicting mortality risk at the time of hospital transfer to a higher level of care.
PLoS One
; 16(2): e0246669, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33556123
11.
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Open Forum Infect Dis
; 8(7): ofab254, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250192
12.
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
Trials
; 22(1): 363, 2021 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34034784
13.
Validation of the Risk Analysis Index for Evaluating Frailty in Ambulatory Patients.
J Am Geriatr Soc
; 68(8): 1818-1824, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32310317
14.
Changes in blood product utilization in a seven-hospital system after the implementation of a patient blood management program: A 9-year follow-up.
Hematology
; 21(8): 490-9, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26870887
15.
The effect of automated alerts on preoperative anemia management.
Hematology
; 20(3): 160-4, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25148476
16.
Transforming care at the bedside: an ambulatory model for improving the patient experience.
J Nurs Adm
; 38(4): 194-9, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18403993